News | January 13, 2025
Apotex acquires US rights to PROVIGIL and NUVIGIL
PROVIGIL and NUVIGIL are indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy
PROVIGIL and NUVIGIL are indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy
Dr. Smith brings 30 years of clinical and translational research experience in obesity, diabetes, and metabolism with over 300 scientific publications
Lonza to develop spray-dried formulations for an intranasally-delivered biologic for Iconovo at its Center of Excellence for bioavailability enhancement and inhaled delivery in Bend (US)
The transaction is part of a broader agreement with Bureau Veritas covering its worldwide food laboratory testing activities
Acquisition expands high-value medical platform
Lilly plans to hire approximately more than 1,000 new highly-skilled team members
Menkes disease is a rare X-linked recessive pediatric disease caused by gene mutations of the copper transporter ATP7A
These three NDAs of Sitagliptin (base) and combination franchise have been approved by the USFDA earlier through the 505(b)(2) route
Prithwish has close to 28 years of experience in a Commercial role
He is an experienced professional in the pharmaceutical industry with about 30 years of progressive experience
Subscribe To Our Newsletter & Stay Updated
